China NMPA Product Recall - microelectrode driver

Medtronic (Shanghai) Management Co., Ltd. initiated a voluntary, Level 1 recall of specific Microelectrode Drivers (models FC1006, FC1017, FC1020). The recall, reported on August 26, 2016, and published by the National Medical Products Administration (NMPA) on September 30, 2016, concerned 83 units across three specific batch numbers distributed in China. The main regulatory violation stemmed from the discovery that these affected products were manufactured before the official approval date of their registration certificate issued by the China NMPA. This timing discrepancy meant the products did not comply with NMPA regulatory requirements for market authorization. Despite the non-compliance, Medtronic confirmed that the manufacturing process adhered strictly to production requirements, ensuring no adverse impact on patient safety or product efficacy. Therefore, no specific actions were required for products already in use, and patient care was to continue as usual. The company's required actions included dispatching notification letters to stakeholders and physically recalling all unused affected products. These collected units were subsequently to be returned to Medtronic's U.S. headquarters. This recall underscores the importance of strict adherence to regulatory timelines for medical device market entry.